Treatment of postmenopausal osteoporosis
Liu, A.C.
New England Journal of Medicine 339(3): 202; Author Reply 203
1998
ISSN/ISBN: 0028-4793 PMID: 9669920 Document Number: 496358
Document emailed within 1 workday
Related Documents
Chapurlat, R.; Delmas, P.D. 2004: Treatment of postmenopausal osteoporosis La Revue du Praticien 54(19): 2120-2126Kotova, S.M.; Alesov, V.Z.; Karlova, N.A.; Aleksenko, N.I.; Fedorova, A.V.; Lebedeva, N.A.; Kudriashova, G.P.; Sokhor, A.Ia. 1990: Treatment of patients with postmenopausal osteoporosis Klinicheskaia Meditsina 68(4): 88-92
Schwartz, M.; Anwah, I.; Levy, R.N. 1985: Variations in treatment of postmenopausal osteoporosis Clinical Orthopaedics and Related Research 192: 180-184
Terranova, R.; Luca, S. 1999: Treatment of postmenopausal osteoporosis with etidronate Minerva Medica 90(3): 85-90
Reginster, J.Y. 2006: Ibandronate (Bonviva) in the treatment of postmenopausal osteoporosis Revue Medicale de Liege 61(11): 783-786
Ismal, N.M. 1997: Postmenopausal osteoporosis: epidemiology, pathophysiology and treatment Malaysian Journal of Pathology 19(1): 21-25
Liu, J-li. 2005: Diagnosis, treatment and prevention of postmenopausal osteoporosis Zhonghua Fu Chan Ke Za Zhi 40(12): 793-795
Alexandersen, P.; Toussaint, A.; Christiansen, C.; Devogelaer, J.P.; Roux, C.; Fechtenbaum, J.; Gennari, C.; Reginster, J.Y. 2001: Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial JAMA 285(11): 1482-1488
Wulff, R.; Abrahamsen, B.; Ejersted, C.Albjerg.; Christensen, P.Mark.; Brixen, K.T. 2004: Compliance with the treatment of osteoporosis with diphosphonates. A questionnaire among postmenopausal women Ugeskrift for Laeger 166(1-2): 49-53
Meczekalski, B.ła.; Czyzyk, A. 2009: Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis Ginekologia Polska 80(3): 213-217
Adam, M.; Spacek, P.; Hulejová, H.; Galiánová, A.; Blahos, J. 1996: Postmenopausal osteoporosis. Treatment with calcitonin and a diet rich in collagen proteins Casopis Lekaru Ceskych 135(3): 74-78
Rossini, M.; Di Munno, O.; Gatti, D.; Giannini, S.; Minisola, S.; Varenna, M.; Adami, S. 2011: Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience Clinical and Experimental Rheumatology 29(4): 728-735
Jiang, Y.; Li, M.; Xia, W.; Xing, X.; Yu, W.; Tian, J.; Meng, X.; Zhou, X. 2002: Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal Zhonghua Yi Xue Za Zhi 82(18): 1254-1256
Hassager, C. 1991: Soft tissue body composition during prevention and treatment of postmenopausal osteoporosis assessed by photon absorptiometry Danish Medical Bulletin 38(5): 380-389
Abellán Pérez, M.; Bayina García, F.J.; Calabozo, M.; Carpintero Benítez, P.; Figueroa Pedrosa, M.; Fernández Crisóstomo, C.; García López, A.; García Pérez, S.; Mesa Ramos, M.; Paulino Tevar, J. 1995: Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis Anales de Medicina Interna 12(1): 12-16
Tolino, A.; Romano, L.; Ronsini, S.; Riccio, S.; Montemagno, U. 1993: Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns International Journal of Clinical Pharmacology Therapy and Toxicology 31(7): 358-360
Rohr, C.I.; Clements, J.M.; Sarkar, A. 2006: Treatment and prevention practices in postmenopausal women after bone mineral density screening at a community-based osteoporosis project Journal of the American Osteopathic Association 106(7): 396-401
Rugpolmuang, L.; Waikakul, S. 2015: Effect of a Short-Term Treatment with Once-A-Week Medication of Alendronate 70 Mg on Bone Turnover Markers in Postmenopausal Women with Osteoporosis Journal of the Medical Association of Thailand 98(Suppl 8): S70-S75
Iwamoto, J. 2010: Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis Clinical Calcium 20(3): 396-407
Bumbasirević, M.; Lesić, A.; Denić-Marković, L.; Zivković, K.; Krnjić, V.; Ille, M.; Tulić, G.; Elez, G.; Mitrović, M.; Tatić, S.; Kecojević, V.; Miljević, A.; Basarić, V.; Antić, Z.; Djurić, R.; Vidanović, M.; Jović, P.; Rašović, P.; Vukičević, A.; Živanović; Kovačević; Timović, V.; Stefanović, M.; Bokun, Ž.; Ranković, V.; Jovanović, Z.; Djoković, N.; Friščić, Ž.; Jovanović, V.; Vidić, G.; Milenković, S.; Matijević, R.; Mićunović, L.; Zagorac, S.; Milovančević, R.; Ristić, L.; Rubežić, R.; Marić, M.; Pešić, R.; Djordjević, Z.; Ilić, S.; Jovanović, S.; Milovanović, P.; Stamatović, V.; Stoiljković, G.; Ravanić, B.; Kostić, D.; Perović, M.; Radosavljević, A 2011: Prospective clinical study of once monthly ibandronate in the treatment of osteoporosis and prevention of fractures in postmenopausal women: ORPHEUM Study Srpski Arhiv Za Celokupno Lekarstvo 139(11-12): 790-794